Perioperative cefuroxime pharmacokinetics in cardiac surgery

OBJECTIVE: The objective was to investigate the plasma levels and to compare the pharmacokinetics of cefuroxime during and after surgery in adult patients with elective indication for coronary artery bypass grafting. METHODS: Seventeen patients received three 1.5-g bolus IV doses of cefuroxime, one every 12 hrs. Serial blood samples (3 mL) were collected 1, 3, 6, 9, and 12 hrs after the first dose (given during the intervention) and after the second and third doses (postsurgery). Blood samples were centrifuged and stored frozen until being assayed. For assessment of the cefuroxime plasma levels by liquid chromatography, only 200 µL of plasma were required. Determination of cefuroxime plasma levels was followed by a pharmacokinetic (PK)-modeling using PK Solutions 2.0 software. RESULTS: The kinetic parameters obtained remained unchanged after the first, second, and the third dose as follows: elimination half-life: 1.8 h, 1.9 h, and 1.8 h; clearance: 1.4, 1.5, and 1.5 mL/min/kg, respectively. Additionally, the apparent volume of distribution did not change during and after the intervention: 0.19, 0.25, and 0.22 L/kg, after the first, second, and the third dose, respectively. Since the drug has a low volume of distribution, plasma levels obtained after a 1.5-g IV bolus injection of cefuroxime decreased rapidly due to the high plasma clearance, with a consequent short half-life. CONCLUSIONS: The kinetic disposition of cefuroxime remains unaltered in patients undergoing coronary artery bypass grafting; to reduce the fluctuation in plasma concentrations so that the antibiotic prophylaxis in the peri-operative period is guaranteed, the dose regimen should be reviewed.

Na minha lista:
Detalhes bibliográficos
Principais autores: Nascimento,Jorge Willian Leandro, Carmona,Maria José Carvalho, Strabelli,Tânia Mara Varejão, Auler Jr,José Otávio Costa, Santos,Sílvia Regina Cavani Jorge
Formato: Digital revista
Idioma:English
Publicado em: Faculdade de Medicina / USP 2007
Acesso em linha:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322007000300009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
id oai:scielo:S1807-59322007000300009
record_format ojs
spelling oai:scielo:S1807-593220070003000092007-06-18Perioperative cefuroxime pharmacokinetics in cardiac surgeryNascimento,Jorge Willian LeandroCarmona,Maria José CarvalhoStrabelli,Tânia Mara VarejãoAuler Jr,José Otávio CostaSantos,Sílvia Regina Cavani Jorge Cefuroxime Pharmacokinetics Antibiotic prophylaxis HPLC Heart surgery OBJECTIVE: The objective was to investigate the plasma levels and to compare the pharmacokinetics of cefuroxime during and after surgery in adult patients with elective indication for coronary artery bypass grafting. METHODS: Seventeen patients received three 1.5-g bolus IV doses of cefuroxime, one every 12 hrs. Serial blood samples (3 mL) were collected 1, 3, 6, 9, and 12 hrs after the first dose (given during the intervention) and after the second and third doses (postsurgery). Blood samples were centrifuged and stored frozen until being assayed. For assessment of the cefuroxime plasma levels by liquid chromatography, only 200 µL of plasma were required. Determination of cefuroxime plasma levels was followed by a pharmacokinetic (PK)-modeling using PK Solutions 2.0 software. RESULTS: The kinetic parameters obtained remained unchanged after the first, second, and the third dose as follows: elimination half-life: 1.8 h, 1.9 h, and 1.8 h; clearance: 1.4, 1.5, and 1.5 mL/min/kg, respectively. Additionally, the apparent volume of distribution did not change during and after the intervention: 0.19, 0.25, and 0.22 L/kg, after the first, second, and the third dose, respectively. Since the drug has a low volume of distribution, plasma levels obtained after a 1.5-g IV bolus injection of cefuroxime decreased rapidly due to the high plasma clearance, with a consequent short half-life. CONCLUSIONS: The kinetic disposition of cefuroxime remains unaltered in patients undergoing coronary artery bypass grafting; to reduce the fluctuation in plasma concentrations so that the antibiotic prophylaxis in the peri-operative period is guaranteed, the dose regimen should be reviewed.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.62 n.3 20072007-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322007000300009en10.1590/S1807-59322007000300009
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Nascimento,Jorge Willian Leandro
Carmona,Maria José Carvalho
Strabelli,Tânia Mara Varejão
Auler Jr,José Otávio Costa
Santos,Sílvia Regina Cavani Jorge
spellingShingle Nascimento,Jorge Willian Leandro
Carmona,Maria José Carvalho
Strabelli,Tânia Mara Varejão
Auler Jr,José Otávio Costa
Santos,Sílvia Regina Cavani Jorge
Perioperative cefuroxime pharmacokinetics in cardiac surgery
author_facet Nascimento,Jorge Willian Leandro
Carmona,Maria José Carvalho
Strabelli,Tânia Mara Varejão
Auler Jr,José Otávio Costa
Santos,Sílvia Regina Cavani Jorge
author_sort Nascimento,Jorge Willian Leandro
title Perioperative cefuroxime pharmacokinetics in cardiac surgery
title_short Perioperative cefuroxime pharmacokinetics in cardiac surgery
title_full Perioperative cefuroxime pharmacokinetics in cardiac surgery
title_fullStr Perioperative cefuroxime pharmacokinetics in cardiac surgery
title_full_unstemmed Perioperative cefuroxime pharmacokinetics in cardiac surgery
title_sort perioperative cefuroxime pharmacokinetics in cardiac surgery
description OBJECTIVE: The objective was to investigate the plasma levels and to compare the pharmacokinetics of cefuroxime during and after surgery in adult patients with elective indication for coronary artery bypass grafting. METHODS: Seventeen patients received three 1.5-g bolus IV doses of cefuroxime, one every 12 hrs. Serial blood samples (3 mL) were collected 1, 3, 6, 9, and 12 hrs after the first dose (given during the intervention) and after the second and third doses (postsurgery). Blood samples were centrifuged and stored frozen until being assayed. For assessment of the cefuroxime plasma levels by liquid chromatography, only 200 µL of plasma were required. Determination of cefuroxime plasma levels was followed by a pharmacokinetic (PK)-modeling using PK Solutions 2.0 software. RESULTS: The kinetic parameters obtained remained unchanged after the first, second, and the third dose as follows: elimination half-life: 1.8 h, 1.9 h, and 1.8 h; clearance: 1.4, 1.5, and 1.5 mL/min/kg, respectively. Additionally, the apparent volume of distribution did not change during and after the intervention: 0.19, 0.25, and 0.22 L/kg, after the first, second, and the third dose, respectively. Since the drug has a low volume of distribution, plasma levels obtained after a 1.5-g IV bolus injection of cefuroxime decreased rapidly due to the high plasma clearance, with a consequent short half-life. CONCLUSIONS: The kinetic disposition of cefuroxime remains unaltered in patients undergoing coronary artery bypass grafting; to reduce the fluctuation in plasma concentrations so that the antibiotic prophylaxis in the peri-operative period is guaranteed, the dose regimen should be reviewed.
publisher Faculdade de Medicina / USP
publishDate 2007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322007000300009
work_keys_str_mv AT nascimentojorgewillianleandro perioperativecefuroximepharmacokineticsincardiacsurgery
AT carmonamariajosecarvalho perioperativecefuroximepharmacokineticsincardiacsurgery
AT strabellitaniamaravarejao perioperativecefuroximepharmacokineticsincardiacsurgery
AT aulerjrjoseotaviocosta perioperativecefuroximepharmacokineticsincardiacsurgery
AT santossilviareginacavanijorge perioperativecefuroximepharmacokineticsincardiacsurgery
_version_ 1756431999303680000